Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gaby Inc GABLF

GABY Inc. is a Canada-based company, which has retail focus and is the owner of the Mankind dispensary in San Diego, California. The Company packages and/or markets, for its own proprietary brands, as well as for third parties, a variety of cannabis products, including flower, concentrates, pre-rolls, edibles, topicals, tinctures and other products derived from or infused with cannabis or hemp. It holds a retail storefront license issued by the Department of Cannabis Control (DCC). It has launched two THC brands in the California market. The Company also owns cannabidiol (CBD) brands and sells those brands in the mainstream market and on-line. The Company’s brands include Mankind Dispensary, Dank Space, Kind Republic, Freedom Grams, Lulu’s Chocolate and 2Rise Naturals. Its flagship Mankind Dispensary serves approximately 25,000 people a month.


GREY:GABLF - Post by User

Post by olive15on Jan 10, 2020 5:18pm
162 Views
Post# 30540693

Forward Looking

Forward LookingI watched this stock fall from .40 to .06. And suffered b/c I'm a shareholder. Still, insider activity tells me that this company is far from dead. Rather, they seem to be setting the stage for a runup. Facts:

Nov 13. Charles Mannix appointed as a Director. Mannix contracts to buy at least 500k of GABY shares on open market between now and May at prevailing market rates.

Nov 15. Aaron Browe, VP, buys 25m shares at .13 (cost $3.25m).

Nov 20. Matt Bartlett appointed as a Director. Matt is a partner with Merida Capital (https://www.meridacap.com). Merida dropped 10m into Gaby in a June, 2019, equity raise @ .30 cents/unit. Having lost near 80% value (or about 8m) based on current share price, Matt and Merida have a vested interest in recouping their paper losses.

Dec 5. Mannix buys 2,232,143 shares at .112 (cost 250k).




<< Previous
Bullboard Posts
Next >>